Functionalized aliphatic P2/P2′ analogs of HIV-1 protease inhibitor DMP323

Bioorganic & Medicinal Chemistry Letters
1997.0

Abstract

A series of analogs of HIV protease inhibitor DMP323 containing functionalized aliphatic PZ/p2' groups was prepared and evaluated for HIV protease inhibition and antiviral activity in a cell-based assay. Asymmetric compounds with a 5-hydroxypentyl substituent at P2 and a benzylic substituent at P2' showed increased potency over the corresponding symmetrically substituted analogs.

Knowledge Graph

Similar Paper

Functionalized aliphatic P2/P2′ analogs of HIV-1 protease inhibitor DMP323
Bioorganic & Medicinal Chemistry Letters 1997.0
Potent cyclic urea HIV protease inhibitors with benzofused heterocycles as P2/P2′ groups
Bioorganic & Medicinal Chemistry Letters 1996.0
A bis-[N-3-(1-hydroxy-1-methyl-ethyl)-benzyl)-cyclic urea as a HIV protease inhibitor
Bioorganic & Medicinal Chemistry Letters 1995.0
The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: Modifications of the P1/P1′ residues
Bioorganic & Medicinal Chemistry Letters 1998.0
Synthesis of PotentC<sub>2</sub>-Symmetric, Diol-Based HIV-1 Protease Inhibitors. Investigation of Thioalkyl and Thioaryl P1/P1‘ Substituents
Journal of Medicinal Chemistry 2001.0
Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands
Bioorganic &amp; Medicinal Chemistry Letters 2011.0
Novel pseudosymmetric inhibitors of HIV-1 protease
Bioorganic &amp; Medicinal Chemistry Letters 1993.0
Design of HIV-1 Protease Inhibitors with C3-Substituted Hexahydrocyclopentafuranyl Urethanes as P2-Ligands: Synthesis, Biological Evaluation, and Protein–Ligand X-ray Crystal Structure
Journal of Medicinal Chemistry 2011.0
Novel inhibitors of HIV protease
Bioorganic &amp; Medicinal Chemistry Letters 2000.0
Cyclic HIV Protease Inhibitors:  Synthesis, Conformational Analysis, P2/P2‘ Structure−Activity Relationship, and Molecular Recognition of Cyclic Ureas
Journal of Medicinal Chemistry 1996.0